Smoking marijuana and 9- tetrahydrocannabinol (THC) (dronabinol, Marinol) is used for treating anorexia and weight loss caused by the human immunodeficiency virus-1 (HTV-1). However, there have been concerns that these chemicals may have a negative in
Keywords:
Cannabinoids, Cells, Marijuana, HIV, Δ9- tetrahydrocannabinol (THC).Abstract
Smoking marijuana and 9- tetrahydrocannabinol (THC) (dronabinol, Marinol) is used for treating anorexia and weight loss caused by the human immunodeficiency virus-1 (HTV-1). However, there have been concerns that these chemicals may have a negative influence on the immune systems of HTV-infected persons. The writer has conducted randomised, potential, controlled trial in adults who have HIV-infection and who have been receiving protease inhibitor-that contains high active antiretroviral therapy to assess the usage of marijuana cigarette (3.95 percent THC), dronabinol (2.5 mg), and an oral placebo in adults who have HIV-infection receiving protease inhibitor-containing highly active antiretroviral therapy (HAART). Immunological presentation (flow cytometric quantification of cellular subpopulations, B cells, and natural killer [NK] cells) and immunological function (induced cytokine production, NK cell activity, and lymphoproliferation) tests were carried out at the beginning and on a regular basis.
Downloads
References
S. Abo-Elnazar, M. Moaaz, H. Ghoneim, T. Molokhia, and W. El-Korany, “Th17/Treg imbalance in opioids and cannabinoids addiction: relationship to NF-κB activation in CD4+ T cells,” Egypt. J. Immunol., 2014.
D. I. Abrams et al., “Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized, Placebo Controlled Clinical Trial,” Ann. Intern. Med., 2003, doi: 10.7326/0003-4819-139-4-200308190-00008.
B. M. Bredt, D. Higuera-Alhino, S. B. Shade, S. J. Hebert, J. M. McCune, and D. I. Abrams, “Short-term effects of cannabinoids on immune phenotype and function in HIV-1- infected patients,” J. Clin. Pharmacol., 2002, doi: 10.1002/j.1552-4604.2002.tb06007.x.
L. Brunet et al., “Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: A longitudinal Cohort analysis,” Clin. Infect. Dis., 2013, doi: 10.1093/cid/cit378.
D. W. Cescon, A. V. Page, S. Richardson, M. J. Moore, S. Boerner, and W. L. Gold, “Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer,” J. Clin. Oncol., 2008, doi: 10.1200/JCO.2007.15.2777.
C. Chao et al., “Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men,” Drug Alcohol Depend., 2008, doi: 10.1016/j.drugalcdep.2007.11.010.
M. J. Chusid, J. A. Gelfand, C. Nutter, and A. S. Fauci, “Letter: Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease.,” Ann. Intern. Med., 1975, doi: 10.7326/0003-4819-82-5-682.
Y. Gargani, P. Bishop, and D. W. Denning, “Too many mouldy joints - marijuana and chronic pulmonary aspergillosis,” Mediterr. J. Hematol. Infect. Dis., 2011, doi: 10.4084/MJHID.2011.005.
A. J. Gill and D. L. Kolson, “Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence,” Current HIV/AIDS reports. 2014, doi: 10.1007/s11904-014-0210-3.
R. Hamadeh, A. Ardehali, R. M. Locksley, and M. K. York, “Fatal aspergillosis associated with smoking contaminated
marijuana, in a marrow transplant recipient,” Chest, 1988, doi: 10.1378/chest.94.2.432.
C. Hézode et al., “Erratum: Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C (Hepatology (2005) 42 (63-71)),” Hepatology. 2005, doi: 10.1002/hep.20774.
A. Jatoi, J. ichi Yamashita, J. A. Sloan, P. J. Novotny, H. E. Windschitl, and C. L. Loprinzi, “Does megestrol acetate down-regulate interleukin-6 in patients with cancer associated anorexia and weight loss? A North Central Cancer Treatment Group investigation,” Support. Care Cancer, 2002, doi: 10.1007/s00520-001-0310-7.
T. E. Johnson, R. R. Casiano, J. W. Kronish, D. J. Tse, M. Meldrum, and W. Chang, “Sino-orbital aspergillosis in acquired immunodeficiency syndrome,” Arch. Ophthalmol., 1999, doi: 10.1001/archopht.117.1.57.
